Cost-Effectiveness Analysis of Postoperative Surveillance Protocols Following Radical Surgery for Colorectal Cancer

被引:11
|
作者
Di Cristofaro, L. [2 ]
Scarpa, M. [1 ]
Angriman, I. [2 ]
Perissinotto, E. [3 ]
Ruffolo, C. [2 ]
Frego, M. [2 ]
Erroi, F. [2 ]
机构
[1] Veneto Inst Oncol IOV IRCCS, Dept Oncol Surg, Padua, Italy
[2] Univ Padua, Dept Surg & Gastroenterol Sci, I-35100 Padua, Italy
[3] Univ Padua, Dept Environm Med & Publ Hlth, I-35100 Padua, Italy
关键词
MINIMUM CLINICAL RECOMMENDATIONS; LONG-TERM SURVIVAL; ANASTOMOTIC LEAKAGE; CURATIVE RESECTION; COLON-CANCER; MESORECTAL EXCISION; MUCINOUS CARCINOMA; PROGNOSTIC-FACTORS; 5-YEAR SURVIVAL; RECURRENCE;
D O I
10.1080/00015458.2012.11680791
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction : Up to 30-50% of patients who undergo radical surgery for colorectal cancer (CRC) develop tumor relapse. The aim of this study was to assess various surveillance protocols utilized in a tertiary referral hospital in Northern Italy. Methods : Data concerning 373 consecutive patients who underwent radical surgery for CRC between 1990 and 2006 and whose data had been entered into a prospective database were considered eligible for this study. The overall costs and the percentages of recurrence following the various surveillance protocols were calculated. Results. One hundred two (27.35%) of the patients suffered a recurrence after a mean of 17.6 (95% CI 13.9-21.1) months. The combination of physical examination, colonoscopy, thorax-abdominal computed tomography (CT) scan, and serum carcinoembryonic antigen (CEA) dosage was found to be the most cost/effective one to monitor stages I and H colon cancer; while physical examination, rigid sigmoidoscopy, thorax-abdominal CT scan, and serum CEA dosage were found to be the most cost/effective surveillance to monitor stages III and IV of colon cancer and rectal cancer. Conclusions : Adherence to follow-up guidelines and early detection are vital factors affecting the curability of relapsed cancer in CRC patients who undergo surgery. The first five years after surgery was found to be the most risky period for recurrence. Cost/effectiveness analysis indicate that follow-up protocols should be tailored to the risk of recurrence with the aim of identifying relapse when the disease is at an asymptomatic, presumably more curable stage.
引用
收藏
页码:24 / 32
页数:9
相关论文
共 50 条
  • [21] Cost-Effectiveness Analysis of Local Ablation and Surgery for Liver Metastases of Oligometastatic Colorectal Cancer
    Froelich, Matthias F.
    Schnitzer, Moritz L.
    Rathmann, Nils
    Tollens, Fabian
    Unterrainer, Marcus
    Rennebaum, Shereen
    Seidensticker, Max
    Ricke, Jens
    Rubenthaler, Johannes
    Kunz, Wolfgang G.
    [J]. CANCERS, 2021, 13 (07)
  • [22] Cost-effectiveness analysis of laparoscopic and open surgery in routine Swedish care for colorectal cancer
    Jacob Gehrman
    Eva Angenete
    Ingela Björholt
    Eva Lesén
    Eva Haglind
    [J]. Surgical Endoscopy, 2020, 34 : 4403 - 4412
  • [23] Cost-effectiveness study of an aspirin chemoprevention associated or not with a colonoscopic surveillance in the colorectal cancer
    Francesconi, C.
    Benamouzig, R.
    Launois, R.
    [J]. VALUE IN HEALTH, 2006, 9 (06) : A280 - A280
  • [24] Cost-effectiveness of Colorectal Cancer Screening
    Lansdorp-Vogelaar, Iris
    Knudsen, Amy B.
    Brenner, Hermann
    [J]. EPIDEMIOLOGIC REVIEWS, 2011, 33 (01) : 88 - 100
  • [25] Cost-effectiveness of screening for colorectal cancer
    Budenholzer, B
    Welch, HG
    [J]. ANNALS OF INTERNAL MEDICINE, 2001, 135 (03) : 219 - 219
  • [26] Cost-effectiveness of colorectal cancer screening
    Heresbach, D
    Manfrédi, S
    Branger, B
    Bretagne, JF
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2006, 30 (01): : 44 - 58
  • [27] Cost-effectiveness of cetuximab for colorectal cancer
    Park, Taehwan
    Choi, Chang-ju
    Choi, Yeera
    Suh, Dong-Churl
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2016, 16 (06) : 667 - 677
  • [28] Cost-effectiveness of colorectal Cancer Screening
    Sailer, M.
    [J]. COLOPROCTOLOGY, 2012, 34 (06) : 441 - 442
  • [29] Cost-effectiveness of colorectal cancer screening
    Glick, SN
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (04): : 407 - 408
  • [30] The cost-effectiveness of screening for colorectal cancer
    Telford, Jennifer J.
    Levy, Adrian R.
    Sambrook, Jennifer C.
    Zou, Denise
    Enns, Robert A.
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2010, 182 (12) : 1307 - 1313